Cookies help us deliver our services. By using our services, you agree to our use of cookies.
Learn more
OK
Skip to main content (Press Enter).
Sign In
Skip auxiliary navigation (Press Enter).
Contact Us
Skip main navigation (Press Enter).
Toggle navigation
Search Options
About
What is the AMS
AMS International Scientific Committee
AMS Educational Executive Committee
AMS Ambassadors
Certification & Accreditation
Upcoming Events
Videos & Webinars
International Events
Become a Speaker
Videos On Demand
Education 365
Features
AMS Features
Blogs
Industry
Industry Partners
Become a Sponsor
Features
Blogs
Blog Viewer
Blogs
Development and validation of a prognostic nomogram model in primary cutaneous and subcutaneous soft tissue angiosarcoma
By
- AMS
posted
Aug 25, 2021 02:03 PM
0
Recommend
.
0 comments
0 views
Related Content
Long-term vemurafenib therapy in advanced melanoma patients: cutaneous toxicity and prognostic implications
- AMS
Added Sep 10, 2020
Blog Entry
Trends and risk factors in the antibiotic management of skin and soft tissue infections in the United States
- AMS
Added Jan 28, 2021
Blog Entry
JangoBio Creating First Organoids for Complete Hormone Restoration
- AMS
Added Feb 09, 2022
Blog Entry
Injectable Dermal Fillers Don't Just Fill – They Also Lift, New Study Suggests
- AMS
Added May 11, 2021
Blog Entry
New Webinar now available
- AMS
Added Jun 22, 2020
Blog Entry
Permalink
© 2022 AMS, Aesthetic Multispecialty Society. All Rights Reserved.
Powered by Higher Logic